Log in to search using one of your social media accounts:


Novocure wins reimbursement from Humana for Optune brain cancer device

NovoCure (NSDQ:NVCR) said today it won reimbursement from Humana for treatments with its Optune device for patients with recurrent glioblastoma. The Optune is a mobile device that delivers low-intensity, intermediate frequency, alternating electric fields, referred to as “tumor treating fields,” to inhibit cancer cell replication and cause cancer cell death. The new reimbursement win brings the number of commercial payers covering Optune treatment up to 9, NovoCure said in a press release. In January, NovoCure said  it applied for a supplemental pre-market approval from the FDA for the 2nd generation of its Optune device for treating glioblastoma, a form of brain cancer. The FDA approved Optune’s 1st iteration in April 2011. NovoCure said it pared the weight of the newer version, which hit the European market last October, from 6 pounds to 2.7 pounds using digital signal generation technology. Last December, NovoCure touted positive data from a pivotal Phase III trial of the Optune device in combination with standard-of-care temozolomide for treating newly diagnosed glioblastoma, which was halted early for success. The post Novocure wins reimbursement from Humana for Optune brain cancer device appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Oncology NovoCure Source Type: news

Related Links:

AbstractMetabolic adaptations permit tumor cells to metastasize to and thrive in the brain. Brain metastases continue to present clinical challenges due to rising incidence and resistance to current treatments. Therefore, elucidating altered metabolic pathways in brain metastases may provide new therapeutic targets for the treatment of aggressive disease. Due to the high demand for glucose in the brain, increased glycolytic activity is favored for energy production. Primary tumors that undergo Warburg-like metabolic reprogramming become suited to growth in the brain microenvironment. Indeed, elevated metabolism is a predic...
Source: Clinical and Experimental Metastasis - Category: Cancer & Oncology Source Type: research
Abstract Radiation therapy, a major method of treatment for brain cancer, may cause severe brain injuries after many years. We used a rare and unique cohort of nasopharyngeal carcinoma patients with normal‐appearing brains to study possible early irradiation injury in its presymptomatic phase before severe, irreversible necrosis happens. The aim is to detect any structural or functional imaging biomarker that is sensitive to early irradiation injury, and to understand the recovery and progression of irradiation injury that can shed light on outcome prediction for early clinical intervention. We found an acute increase in...
Source: Human Brain Mapping - Category: Neurology Authors: Tags: Research Article Source Type: research
In this study, we demonstrate that irrespective of the derivation of CD8+ CD45RA+CD27- T cells, these primed cells exhibit a unique highly inflammatory secretory profile characteristic of the SASP, and we also provide evidence that ADAM28 can be used as a functional marker of senescence in CD8+ T cells. Furthermore, we show that the secretory phenotype in CD8+ CD45RA+CD27- T cells is controlled through p38 MAPK signalling, which contributes to age-associated inflammation. Patient Paid Clinical Studies are a Good Plan for Rejuvenation Therapies https://www.fightaging.org/archives/2017/10/patient-paid-clinical-st...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Happy Saturday, sweet readers! It’s a gorgeous day here in my neck of the woods, and trust me when I say we’ll be taking full advantage of it! After all, the days are getting shorter and soon there won’t be as many warm and sunny days (at least, not here) until spring. Many people begin experiencing seasonal affective disorder (SAD) as fall really kicks in. As many of you know, for a lot of people light therapy is an effective way to treat SAD. However, did you also know light therapy might be able to help with bipolar disorder? That’s just one of the topics we’re covering in today’s Psy...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Bipolar Brain and Behavior Celebrities Disorders Industrial and Workplace Policy and Advocacy Professional Psychology Around the Net Research Self-Esteem Stigma Treatment Bipolar Disorder Defense Mechanism Denial Depression Source Type: blogs
Devin Suau was a healthy six-year-old from Massachusetts when he fell off his snowboard in early February. A brain scan to check for concussion revealed an inoperable brain tumor.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Conclusions • Physicians should have no hesitation prescribing natural progesterone. The evidence is clear that progesterone does not cause breast cancer. Indeed, progesterone is protective and preventative of breast cancer. PMID: 29055286 [PubMed - as supplied by publisher]
Source: Alternative Therapies in Health and Medicine - Category: Complementary Medicine Authors: Tags: Altern Ther Health Med Source Type: research
Oral storytelling is an ancient tradition. About a year ago at ​Busboys and Poets in D.C., I told a story through the organizationThe Story Collider. The story I told was about one of my more upsetting effects of cancer treatment, and how I learned to cope –and maybe, in some ways, even improve myself because of it. That story published today and you canhear it here.Some Recent Social Media PostsCelebrating 16 years from from bone cancerMywriting mentor's book,Paris Was the Place...whoa
Source: cancerslayerblog - Category: Cancer & Oncology Tags: cancer treatment writing/speaking Source Type: blogs
This report demonstrates that although cases of esophageal adenocarcinoma that present as brain metastases typically carry a poor prognosis, with early and aggressive treatment patients can survive well past one year after diagnosis.Case Rep Oncol 2017;10:938 –944
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research
See something of interest? Please share our postings with colleagues in your institutions! Spotlight New funding available! The National Network of Libraries of Medicine, Middle Atlantic Region, is pleased to announce a new round of funding for health information outreach, health literacy initiatives, emergency preparedness partnerships and health sciences library projects. Applications will be due by COB on December 1. See a recent blog post from Executive Director, Kate Flewelling for details, or review our funding opportunities and start your application today! Apply Today! Health science librarians are invited to parti...
Source: NN/LM Middle Atlantic Region Blog - Category: Databases & Libraries Authors: Tags: Weekly Postings Source Type: news
This study identified FSTL1 as an inhibitor of cell proliferation in MDA‑MB‑231 and 231‑BR cell lines, which may provide new insights into the development and management of breast cancer. PMID: 29048681 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Medical Devices | Neurology | Temodar